Purpose

The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Participants will perform computerized tasks immediately before and after the stimulation, while EEG, heart rate, and skin temperature will be recorded. These recordings will be used to assess if TMS can be used to improve tolerance to misophonia triggers.

Condition

Eligibility

Eligible Ages
Between 18 Years and 55 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear. - Must be between the ages of 18 - 55. - Must be fluent in English since the study's instructions, surveys, and tasks will be in English.

Exclusion Criteria

  • Epilepsy or previous episode of convulsion or seizure. - Previous episode of fainting spell or syncope. - Head trauma. - Hearing problems. - Cochlear implant. - Metal in the brain, skull, or anywhere else in the body (e.g., splinters, fragments, clips, etc.). - Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS). - Presence of cardiac pacemaker or intracardiac lines. - Presence of medication infusion device. - Use of pro-convulsant or epileptogenic medications. - Pregnancy. The risks associated with TMS exposure during gestation have not been studied extensively. We wish to safeguard the health of potential participants and their children. - Lactation. The risks associated with TMS during lactation and its effects on infant development have not been studied. We wish to safeguard the health of potential participants and their children. - Presence of Mania, Psychosis, Antisocial Personality Disorder, Borderline Personality Disorder, and Suicidal Ideation.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Intervention Model Description
Participants will undergo two sessions of TMS, one inhibitory and another excitatory. The immediate changes resulting from both will be measured and compared.
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description
This is a TMS study. Only the technician administering TMS will be unblinded. All parties will be blinded till the end of the study. The technician is not involved in the data analysis.

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Inhibitory-Excitatory (IE) then Excitatory-Inhibitory (EI)
Participants in this group will receive an inhibitory TMS in the first session and an excitatory TMS in the second session. The two sessions will be separated by 72 hours.
  • Other: Transcranial Magnetic Stimulation (TMS)
    Transcranial Magnetic Stimulation (TMS) is an FDA-approved non-invasive brain stimulation technology. It is currently used for treating depression. Applications to other disorders such as OCD and anxiety using TMS are currently under investigation. TMS will be administered for 25 minutes.
Active Comparator
Excitatory-Inhibitory (EI) then Inhibitory-Excitatory (IE)
Participants in this group will receive an excitatory TMS in the first session and an inhibitory TMS in the second session. The two sessions will be separated by 72 hours.
  • Other: Transcranial Magnetic Stimulation (TMS)
    Transcranial Magnetic Stimulation (TMS) is an FDA-approved non-invasive brain stimulation technology. It is currently used for treating depression. Applications to other disorders such as OCD and anxiety using TMS are currently under investigation. TMS will be administered for 25 minutes.

Recruiting Locations

Mount Sinai West
New York, New York 10022
Contact:
Daniela Schiller, PhD
daniela.schiller@mssm.edu

More Details

Status
Recruiting
Sponsor
Icahn School of Medicine at Mount Sinai

Study Contact

Shama Patel
347-670-4878
shama.patel@mssm.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.